Business Context and Reporting Period
This Form 8-K was filed by Integrity Applications, Inc. (note: the request metadata lists "Glucotrack, Inc." but the filing text identifies the registrant as Integrity Applications, Inc.) on June 14, 2019. The report details the final closing of a private placement of securities (the "D Round") with accredited investors.
Key Financial Metrics
- Gross Proceeds: $3,604,800 received in the final closing.
- Units Issued: 13,972,100 units.
- Purchase Price: $0.258 per unit.
- Unit Composition: Each unit consists of one share of common stock and three types of five-year warrants (Series D-1, D-2, and D-3).
- Warrant Exercise Prices: $1.80 (Series D-1), $3.60 (Series D-2), and $5.40 (Series D-3).
- Placement Agent Compensation: 7% cash commission, 3% management fee, 3% expense allowance, plus warrants equal to 10% of shares and 10% of warrants sold.
Material Changes
The filing reports the completion of a capital raise event. The terms of the instruments issued in this final closing are consistent with previous closings of the "D Round" described in an 8-K filed on March 7, 2018. No prior period financial performance data (revenue, profit, or cash flow) is provided in this specific filing.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard legal disclaimers regarding the summary of terms. The securities were sold unregistered under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D.
Investor Verification Checklist
- Verify the correct registrant name (Integrity Applications, Inc.) versus the metadata provided (Glucotrack, Inc.).
- Confirm the total aggregate proceeds raised across all closings of the "D Round" by reviewing the March 7, 2018, 8-K filing.
- Review the full text of the Securities Purchase Agreement and Warrant agreements filed as exhibits to understand dilution mechanics and anti-dilution protections.
- Assess the impact of the 10% placement agent warrants (which include full ratchet anti-dilution protection) on existing shareholders.